Cancer Research Technology
Log in Register
Menu

Anti-VEGF [VG-1]

Invented by Helen Turley at University of Oxford

Info

Catalogue Number 151258
Applications ELISA IHC IF IP WB
Antigen/Gene or Protein Targets Vascular Endothelial Growth Factor (VEGF)
Reactivity Human
Relevance VEGF is an angiogenic growth factor and a prognostic indicator for cancer when detected in serum. VG-1 is useful for studies of VEGF and angiogenesis in human pathological material.
Host Mouse
Immunogen Recombinant VEGF Protein
Subclass IgG1
Positive Control Corpus luteum, VEGF165 recombinant protein, astrocytoma or hemoangiosarcoma.
Molecular Weight (kDa) 19-22
Myeloma Used P3/NS1/1-Ag4.1
Recommended Growing Conditions IMDM + 15% FCS (HAT may be required) to recover.DMEM + 10% FCS
Strain Balb/c
Notes VG-1 detects the 121, 165 and 185 VEGF isoforms in fixed specimens.
Research Area Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism

References: 8 entries

The role of bone marrow mesenchymal stem cells in the treatment of acute liver failure.

Europe PMC ID: 24312909

Yuan et al. 2013. Biomed Res Int. 2013:251846. PMID: 24312909.

Giatromanolaki et al. 2003. J Pathol. 200(2):222-8. PMID: 12754744.

DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.

Europe PMC ID: 12754744

Hui et al. 2002. Clin Cancer Res. 8(8):2595-604. PMID: 12171890.

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Europe PMC ID: 12171890

Turley et al. 1998. J Pathol. 186(3):313-8. PMID: 10211122.

Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.

Europe PMC ID: 10211122


Add a reference

References: 8 entries

The role of bone marrow mesenchymal stem cells in the treatment of acute liver failure.

Europe PMC ID: 24312909

Yuan et al. 2013. Biomed Res Int. 2013:251846. PMID: 24312909.

Giatromanolaki et al. 2003. J Pathol. 200(2):222-8. PMID: 12754744.

DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.

Europe PMC ID: 12754744

Hui et al. 2002. Clin Cancer Res. 8(8):2595-604. PMID: 12171890.

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Europe PMC ID: 12171890

Turley et al. 1998. J Pathol. 186(3):313-8. PMID: 10211122.

Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.

Europe PMC ID: 10211122


Add a reference

References: 8 entries

The role of bone marrow mesenchymal stem cells in the treatment of acute liver failure.

Yuan et al. 2013. Biomed Res Int. 2013:251846. PMID: 24312909.

Giatromanolaki et al. 2003. J Pathol. 200(2):222-8. PMID: 12754744.

DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.

Hui et al. 2002. Clin Cancer Res. 8(8):2595-604. PMID: 12171890.

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Turley et al. 1998. J Pathol. 186(3):313-8. PMID: 10211122.

Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.


Add a reference


This reagent does not have any reviews at the moment.